Protagonist Therapeutics, Inc - COM (PTGX)

Historical Portfolio Holders from Q3 2016 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
58 M
Holdings value Q1 2024
$1.68 B
Value change Q1 2024
+$66.6 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
177
Number of buys Q1 2024
107
Number of sells Q1 2024
-72
Average buys Q1 2024 %
+0.003%
Average sells Q1 2024 %
-0.003%
CUSIP
74366E102
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 58 M $1.68 B +$66.6 M $28.93 177
2023 Q4 55.8 M $1.28 B -$5.27 M $22.93 152
2023 Q3 56.1 M $936 M -$60.7 M $16.68 140
2023 Q2 56.5 M $1.56 B +$104 M $27.62 165
2023 Q1 52.9 M $1.22 B +$180 M $23.00 135
2022 Q4 48.8 M $532 M +$12.5 M $10.91 134
2022 Q3 46.9 M $396 M -$36.9 M $8.43 127
2022 Q2 52.3 M $413 M -$73 M $7.91 128
2022 Q1 50.3 M $1.19 B +$11.4 M $23.68 137
2021 Q4 49.1 M $1.68 B +$93.9 M $34.20 141
2021 Q3 46.2 M $818 M -$247 M $17.72 124
2021 Q2 48 M $2.15 B +$180 M $44.88 135
2021 Q1 43.8 M $1.13 B +$29.7 M $25.90 122
2020 Q4 40.2 M $811 M +$97.7 M $20.16 118
2020 Q3 37.2 M $727 M +$62.3 M $19.55 89
2020 Q2 33.2 M $586 M +$211 M $17.66 79
2020 Q1 22.3 M $158 M +$1.1 M $7.06 71
2019 Q4 23.1 M $163 M +$7.99 M $7.05 74
2019 Q3 18.9 M $227 M +$20.8 M $12.01 68
2019 Q2 17.2 M $208 M +$26.4 M $12.11 61
2019 Q1 15.1 M $189 M +$22.1 M $12.57 61
2018 Q4 13.9 M $93.2 M -$9.55 M $6.73 61
2018 Q3 16 M $164 M +$27 M $10.29 58
2018 Q2 13.9 M $93.6 M +$10.9 M $6.72 67
2018 Q1 11.9 M $103 M -$12 M $8.59 67
2017 Q4 10.9 M $226 M +$77.2 M $20.80 63
2017 Q3 8.13 M $144 M +$629 K $17.67 41
2017 Q2 8.11 M $91.8 M -$283 K $11.31 39
2017 Q1 8.01 M $103 M +$4.47 M $12.81 39
2016 Q4 7.98 M $175 M +$2.37 M $21.99 38
2016 Q3 6.9 M $145 M +$145 M $21.13 34